Systematic review of hematopoietic stem cell gene therapy approach in thalassemia: Comparative analysis in animal models
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14179 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Indira Laksmi Maharani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Undergraduate Medical Program, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia. Hauptthemen laut MEDLINE: Disease Models, Animal, Genetic Therapy, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Hematopoietic stem cell (HSC) gene therapy has shown potential as a therapeutic approach for thalassemia in recent years. However, a comparison of the varying gene therapy methods of HSC gene therapy in thalassemia has never been reviewed. This study aims to evaluate the utilization of HSC gene therapy approaches in animal models of thalassemia. A systematic review was conducted in five databases: PubMed, EBSCOHost, Science Direct, SCOPUS, and Proquest using a combination of the terms hematopoietic stem cell or hematopoietic stem cell or HSC, thalassemia, genetic therapy or gene therapy and animal model. Only journals published in English between 2008 and 2023 were included. This literature included six studies analyzing the use of HSC gene therapy in thalassemic mice models. The three outcomes being assessed in this review were globin levels, hematological parameters, and red blood cell (RBC) phenotypes. Gene therapy approaches for thalassemia using HSC showed significant improvement in β‐globin levels and RBC phenotypes. Phenotypic improvements were also observed. These outcomes indicate good efficacy in gene therapy for thalassemia in mice models. Furthermore, more studies assessing the efficacy of HSC gene therapy in the human model should be done in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Undergraduate Medical Program, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
- Department of Medical Pharmacy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Department of Medical Physiology and Biophysics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Stem Cell and Tissue Engineering Cluster, The Indonesian Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
ORCID-Profile: Indira Laksmi Maharani, Muhammad Hafizh Zauhari, Rakean Ahmad Kiansantang, Razzan Satria Wibowo, Rizqi Najla Humaira, Adisti Dwijayanti, Imelda Rosalyn Sianipar
Zitieren
APA
Maharani, I. L., Zauhari, M. H., Kiansantang, R. A., Wibowo, R. S., Humaira, R. N., Dwijayanti, A., & Sianipar, I. R. (2024). Systematic review of hematopoietic stem cell gene therapy approach in thalassemia: Comparative analysis in animal models. European Journal of Haematology. https://doi.org/10.1111/ejh.14179
Vancouver
Maharani IL, Zauhari MH, Kiansantang RA, Wibowo RS, Humaira RN, Dwijayanti A, et al. Systematic review of hematopoietic stem cell gene therapy approach in thalassemia: Comparative analysis in animal models. European Journal of Haematology. 2024. doi:10.1111/ejh.14179
BibTeX
@article{Maharani2024,
author = {Maharani, Indira Laksmi and Zauhari, Muhammad Hafizh and Kiansantang, Rakean Ahmad and Wibowo, Razzan Satria and Humaira, Rizqi Najla and Dwijayanti, Adisti and Sianipar, Imelda Rosalyn},
title = {Systematic review of hematopoietic stem cell gene therapy approach in thalassemia: Comparative analysis in animal models},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14179}
}
EUVIMED